119 filings
Page 6 of 6
8-K/A
bjmv2lecz
3 Apr 19
Index to Consolidated Financial Statements
12:00am
8-K
il3dqy5qp ypqkfyrc6
2 Apr 19
Departure of Directors or Certain Officers
8:37am
8-K
ov2d8agiuuor4bb1m
1 Apr 19
Regulation FD Disclosure
9:26am
8-K
awttp30ngn
13 Mar 19
X4 Pharmaceuticals Completes Merger with Arsanis
5:28pm
8-K
w451a0b2hied pwpwt1
8 Mar 19
Entry into a Material Definitive Agreement
5:14pm
8-K
ruxjq1y5
1 Mar 19
Termination of a Material Definitive Agreement
4:38pm
8-K
22bx100f9m6cb3n
8 Feb 19
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
4:27pm
8-K
l2luxjfhr892yk
16 Jan 19
Departure of Directors or Certain Officers
5:01pm
8-K
txsc31b4 0h3lxx
20 Dec 18
Entry into a Material Definitive Agreement
5:09pm
8-K
i8s96
27 Nov 18
Other Events
5:22pm
8-K
2hf3ehi1yvoh
27 Nov 18
Entry into a Material Definitive Agreement
7:10am
8-K
th3owtayudz bmvu
9 Nov 18
Arsanis Reports Financial Results for Third Quarter 2018
8:15am
8-K
z3j cptfjsm657
13 Aug 18
Arsanis Reports Financial Results for Second Quarter 2018
8:18am
8-K
pwu2i
28 Jun 18
Arsanis Provides Update Following Completion of Planned Interim Analysis
7:11am
8-K
qko0w3r10
12 Jun 18
Entry into a Material Definitive Agreement
12:00am
8-K
6gfsg
7 Jun 18
Submission of Matters to a Vote of Security Holders
4:38pm
8-K
ettikqriwlrv29idi3u
10 May 18
Arsanis Reports Business Highlights and Financial Results for First Quarter 2018
7:38am
8-K
d8lthbm
9 Mar 18
Arsanis Reports Financial Results and Highlights for Fourth Quarter and Full Year 2017
12:00am
8-K
uo8aqxn 4r0onl63
20 Nov 17
Amendments to Articles of Incorporation or Bylaws
12:00am